Literature DB >> 16876173

Is periodontal infection behind the failure of antibiotics to prevent coronary events?

Susanna Paju1, Juha Sinisalo, Pirkko J Pussinen, Ville Valtonen, Markku S Nieminen.   

Abstract

The use of antimicrobial agents to prevent coronary events is under debate. They have reduced cardiovascular events in some studies, but in others, their effect has not been distinguishable from that of placebo. In addition to Chlamydophila (Chlamydia) pneumoniae as a target pathogen, very few other microbes or infections have been targeted, although an association for instance between cardiovascular disease and periodontitis has been established. In our recent pilot study, long-term clarithromycin treatment reduces recurrent cardiovascular events in subjects without periodontitis, but in subjects with periodontitis, fails to show any effect. As a background infection, periodontitis may overpower the beneficial effects of antibiotics. This paper presents the hypothesis that periodontitis is behind the failure of antibiotics to prevent coronary events. We discuss the systemic effects of periodontal infection and consider studies to test our hypothesis, which offers a novel viewpoint for discussion of antibiotics in coronary-disease prevention.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16876173     DOI: 10.1016/j.atherosclerosis.2006.06.015

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  7 in total

Review 1.  Bacterial invasion of vascular cell types: vascular infectology and atherogenesis.

Authors:  Emil Kozarov
Journal:  Future Cardiol       Date:  2012-01

2.  Impact of monocytic cells on recovery of uncultivable bacteria from atherosclerotic lesions.

Authors:  B Rafferty; D Jönsson; S Kalachikov; R T Demmer; R Nowygrod; M S V Elkind; H Bush; E Kozarov
Journal:  J Intern Med       Date:  2011-04-11       Impact factor: 8.989

3.  Lipoproteins and lipoprotein metabolism in periodontal disease.

Authors:  Rachel Griffiths; Suzanne Barbour
Journal:  Clin Lipidol       Date:  2010-06

4.  Cross-reacting antibacterial auto-antibodies are produced within coronary atherosclerotic plaques of acute coronary syndrome patients.

Authors:  Filippo Canducci; Diego Saita; Chiara Foglieni; Maria Rosaria Piscopiello; Roberto Chiesa; Antonio Colombo; Domenico Cianflone; Attilio Maseri; Massimo Clementi; Roberto Burioni
Journal:  PLoS One       Date:  2012-08-06       Impact factor: 3.240

5.  Cholesterol, C-Reactive Protein, and Periodontitis: HMG-CoA-Reductase Inhibitors (Statins) as Effect Modifiers.

Authors:  Peter Meisel; Thomas Kohlmann; Henri Wallaschofski; Heyo K Kroemer; Thomas Kocher
Journal:  ISRN Dent       Date:  2011-11-16

6.  Pro-atherogenic lung and oral pathogens induce an inflammatory response in human and mouse mast cells.

Authors:  Anna Oksaharju; Jani Lappalainen; Anita M Tuomainen; Pirkko J Pussinen; Mirja Puolakkainen; Petri T Kovanen; Ken A Lindstedt
Journal:  J Cell Mol Med       Date:  2009-01       Impact factor: 5.310

Review 7.  Comparing the Antimicrobial In Vitro Efficacy of Amoxicillin/Metronidazole against Azithromycin-A Systematic Review.

Authors:  Manuela Kaufmann; Patrik Lenherr; Clemens Walter; Thomas Thurnheer; Thomas Attin; Daniel B Wiedemeier; Patrick R Schmidlin
Journal:  Dent J (Basel)       Date:  2018-10-20
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.